Blood Screening Market By Product Type (Reagents & Kits, Instruments, Software), By Technology (Nucleic Acid Testing (NAT), ELISA, Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)), By Application (Infectious Disease Detection, Blood Group Typing, Cancer Detection, Metabolic Disorders, Drug Testing, Others), By End-user (Blood Banks, Hospitals, Clinical Laboratories, Plasma Donation Centers, Academic & Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Blood Screening Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Rising global blood donations increase the demand for safe and efficient screening methods.

3.2.2. The growing prevalence of infectious diseases fuels the need for advanced diagnostic technologies.

3.2.3. Technological advancements improve accuracy, speed, and automation in blood screening processes.

3.3. Key industry pitfalls & challenges

3.3.1. The high cost of advanced screening technologies limits adoption in low-income healthcare settings.

3.3.2. Lack of skilled professionals hampers accurate operation and maintenance of diagnostic equipment.

3.3.3. Inadequate healthcare infrastructure in developing regions restricts widespread blood screening implementation.

3.4. Market Opportunities

3.4.1. The expansion of healthcare infrastructure in developing regions boosts market penetration and accessibility.

3.4.2. Increasing public awareness about blood safety enhances demand for comprehensive screening programs.

3.4.3. Increasing healthcare spending supports adoption of premium diagnostic and screening technologies.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Blood Screening Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Reagents & Kits

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Instruments

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Software

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Blood Screening Market, Application Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Application, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Nucleic Acid Testing (NAT)

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. ELISA

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Western Blot Assays

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Next-Generation Sequencing (NGS)

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Blood Screening Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Technology, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Infectious Disease Detection

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Blood Group Typing

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Cancer Detection

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Metabolic Disorder

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Drug Testing

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.7. Others

6.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Blood Screening Market, End-user Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-user, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Blood Banks

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Hospitals

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Clinical Laboratories

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Plasma Donation Centers

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.6. Academic & Research Institutes

7.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Blood Screening Market, Region Segment Analysis

8.1. Overview

8.1.1. Global Market Revenue Share, By Region, 2025 & 2035

8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)

8.2.2. North America Market Revenue, By Product Type, 2025-2035

8.2.3. North America Market Revenue, By Application, 2025-2035

8.2.4. North America Market Revenue, By Technology, 2025-2035

8.2.5. North America Market Revenue, By End-user, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Product Type, 2025-2035

8.2.6.2. U.S. Market Revenue, By Application, 2025-2035

8.2.6.3. U.S. Market Revenue, By Technology, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-user, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Product Type, 2025-2035

8.2.7.2. Canada Market Revenue, By Application, 2025-2035

8.2.7.3. Canada Market Revenue, By Technology, 2025-2035

8.2.7.4. Canada Market Revenue, By End-user, 2025-2035

8.3. Europe

8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)

8.3.2. Europe Market Revenue, By Product Type, 2025-2035

8.3.3. Europe Market Revenue, By Application, 2025-2035

8.3.4. Europe Market Revenue, By Technology, 2025-2035

8.3.5. Europe Market Revenue, By End-user, 2025-2035

8.3.6. Germany

8.3.6.1. Germany Market Revenue, By Product Type, 2025-2035

8.3.6.2. Germany Market Revenue, By Application, 2025-2035

8.3.6.3. Germany Market Revenue, By Technology, 2025-2035

8.3.6.4. Germany Market Revenue, By End-user, 2025-2035

8.3.7. France

8.3.7.1. France Market Revenue, By Product Type, 2025-2035

8.3.7.2. France Market Revenue, By Application, 2025-2035

8.3.7.3. France Market Revenue, By Technology, 2025-2035

8.3.7.4. France Market Revenue, By End-user, 2025-2035

8.3.8. U.K.

8.3.8.1. U.K. Market Revenue, By Product Type, 2025-2035

8.3.8.2. U.K. Market Revenue, By Application, 2025-2035

8.3.8.3. U.K. Market Revenue, By Technology, 2025-2035

8.3.8.4. U.K. Market Revenue, By End-user, 2025-2035

8.3.9. Italy

8.3.9.1. Italy Market Revenue, By Product Type, 2025-2035

8.3.9.2. Italy Market Revenue, By Application, 2025-2035

8.3.9.3. Italy Market Revenue, By Technology, 2025-2035

8.3.9.4. Italy Market Revenue, By End-user, 2025-2035

8.3.10. Spain

8.3.10.1. Spain Market Revenue, By Product Type, 2025-2035

8.3.10.2. Spain Market Revenue, By Application, 2025-2035

8.3.10.3. Spain Market Revenue, By Technology, 2025-2035

8.3.10.4. Spain Market Revenue, By End-user, 2025-2035

8.3.11. Rest of Europe

8.3.11.1. Rest of Europe Market Revenue, By Product Type, 2025-2035

8.3.11.2. Rest of Europe Market Revenue, By Application, 2025-2035

8.3.11.3. Rest of Europe Market Revenue, By Technology, 2025-2035

8.3.11.4. Rest of Europe Market Revenue, By End-user, 2025-2035

8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)

8.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

8.4.3. Asia Pacific Market Revenue, By Application, 2025-2035

8.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035

8.4.5. Asia Pacific Market Revenue, By End-user, 2025-2035

8.4.6. China

8.4.6.1. China Market Revenue, By Product Type, 2025-2035

8.4.6.2. China Market Revenue, By Application, 2025-2035

8.4.6.3. China Market Revenue, By Technology, 2025-2035

8.4.6.4. China Market Revenue, By End-user, 2025-2035

8.4.7. Japan

8.4.7.1. Japan Market Revenue, By Product Type, 2025-2035

8.4.7.2. Japan Market Revenue, By Application, 2025-2035

8.4.7.3. Japan Market Revenue, By Technology, 2025-2035

8.4.7.4. Japan Market Revenue, By End-user, 2025-2035

8.4.8. India

8.4.8.1. India Market Revenue, By Product Type, 2025-2035

8.4.8.2. India Market Revenue, By Application, 2025-2035

8.4.8.3. India Market Revenue, By Technology, 2025-2035

8.4.8.4. India Market Revenue, By End-user, 2025-2035

8.4.9. Australia

8.4.9.1. Australia Market Revenue, By Product Type, 2025-2035

8.4.9.2. Australia Market Revenue, By Application, 2025-2035

8.4.9.3. Australia Market Revenue, By Technology, 2025-2035

8.4.9.4. Australia Market Revenue, By End-user, 2025-2035

8.4.10. South Korea

8.4.10.1. South Korea Market Revenue, By Product Type, 2025-2035

8.4.10.2. South Korea Market Revenue, By Application, 2025-2035

8.4.10.3. South Korea Market Revenue, By Technology, 2025-2035

8.4.10.4. South Korea Market Revenue, By End-user, 2025-2035

8.4.11. Singapore

8.4.11.1. Singapore Market Revenue, By Product Type, 2025-2035

8.4.11.2. Singapore Market Revenue, By Application, 2025-2035

8.4.11.3. Singapore Market Revenue, By Technology, 2025-2035

8.4.11.4. Singapore Market Revenue, By End-user, 2025-2035

8.4.12. Rest of Asia Pacific

8.4.12.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

8.4.12.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

8.4.12.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

8.4.12.4. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

8.5. Latin America

8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)

8.5.2. Latin America Market Revenue, By Product Type, 2025-2035

8.5.3. Latin America Market Revenue, By Application, 2025-2035

8.5.4. Latin America Market Revenue, By Technology, 2025-2035

8.5.5. Latin America Market Revenue, By End-user, 2025-2035

8.5.6. Brazil

8.5.6.1. Brazil Market Revenue, By Product Type, 2025-2035

8.5.6.2. Brazil Market Revenue, By Application, 2025-2035

8.5.6.3. Brazil Market Revenue, By Technology, 2025-2035

8.5.6.4. Brazil Market Revenue, By End-user, 2025-2035

8.5.7. Argentina

8.5.7.1. Argentina Market Revenue, By Product Type, 2025-2035

8.5.7.2. Argentina Market Revenue, By Application, 2025-2035

8.5.7.3. Argentina Market Revenue, By Technology, 2025-2035

8.5.7.4. Argentina Market Revenue, By End-user, 2025-2035

8.5.8. Mexico

8.5.8.1. Mexico Market Revenue, By Product Type, 2025-2035

8.5.8.2. Mexico Market Revenue, By Application, 2025-2035

8.5.8.3. Mexico Market Revenue, By Technology, 2025-2035

8.5.8.4. Mexico Market Revenue, By End-user, 2025-2035

8.5.9. Rest of Latin America

8.5.9.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

8.5.9.2. Rest of Latin America Market Revenue, By Application, 2025-2035

8.5.9.3. Rest of Latin America Market Revenue, By Technology, 2025-2035

8.5.9.4. Rest of Latin America Market Revenue, By End-user, 2025-2035

8.6. MEA

8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)

8.6.2. MEA Market Revenue, By Product Type, 2025-2035

8.6.3. MEA Market Revenue, By Application, 2025-2035

8.6.4. MEA Market Revenue, By Technology, 2025-2035

8.6.5. MEA Market Revenue, By End-user, 2025-2035

8.6.6. GCC Countries

8.6.6.1. GCC Countries Market Revenue, By Product Type, 2025-2035

8.6.6.2. GCC Countries Market Revenue, By Application, 2025-2035

8.6.6.3. GCC Countries Market Revenue, By Technology, 2025-2035

8.6.6.4. GCC Countries Market Revenue, By End-user, 2025-2035

8.6.7. South Africa

8.6.7.1. South Africa Market Revenue, By Product Type, 2025-2035

8.6.7.2. South Africa Market Revenue, By Application, 2025-2035

8.6.7.3. South Africa Market Revenue, By Technology, 2025-2035

8.6.7.4. South Africa Market Revenue, By End-user, 2025-2035

8.6.8. Rest of Middle-East & Africa

8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035

8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

8.6.8.3. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

8.6.8.4. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

9. Company Profile

9.1. Abbott Laboratories

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. F. Hoffmann-La Roche Ltd.

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. Grifols, S.A.

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. bioMerieux SA

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. Bio-Rad Laboratories, Inc.

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. Siemens Healthineers AG

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. Thermo Fisher Scientific Inc.

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. Danaher Corporation

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Ortho Clinical Diagnostics Holdings plc

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. Becton, Dickinson and Company

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Product/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. QuidelOrtho Corporation

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Product/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. PerkinElmer, Inc.

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Product/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. Diasorin S.p.A

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Product/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. Merck KGaA

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Product/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. Beckman Coulter, Inc.

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Product/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis